NASDAQ: IMA
Imagenebio Inc Stock Ownership - Who owns Imagenebio?

Insider buying vs selling

Have Imagenebio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph P. SlatteryDirector2025-12-2416,000$5.99
$95.84kBuy
Jotin MarangoChief Financial Officer2025-07-284,630$17.16
$79.45kSell
David P. BonitaDirector2025-07-2583,611$29.90
$2.50MBuy
Orbimed Advisors LLCDirector2025-07-2583,611$2.49
$208.19kBuy
Otello StampacchiaDirector2025-07-25267,556$29.90
$8.00MBuy

1 of 1

IMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMA insiders and whales buy or sell their stock.

IMA Shareholders

What type of owners hold Imagenebio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jean Francois Formela25.95%2,901,609$20.34MInsider
Otello Stampacchia24.19%2,704,484$18.96MInsider
Atlas Venture Fund XI LP18.93%2,116,569$14.84MInsider
Jonathan Jian Wang9.97%1,115,005$7.82MInsider
Deep Track Capital LP7.86%878,516$6.16MInstitution
Bvf Inc7.17%802,102$5.62MInstitution
Atlas Venture Fund X LP6.70%749,634$5.25MInsider
Blue Owl Capital Holdings LP4.84%540,924$3.79MInstitution
Omega Fund Management LLC4.07%455,361$3.19MInstitution
Orbimed Advisors LLC3.39%378,556$2.65MInstitution

1 of 3

IMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMA31.40%68.60%Net BuyingNet Buying
SPRB13.83%86.17%Net SellingNet Selling
MNOV10.46%89.10%
TENX37.09%62.91%Net BuyingNet Buying
IMUX35.49%13.20%Net Buying

Imagenebio Stock Ownership FAQ

Who owns Imagenebio?

Imagenebio (NASDAQ: IMA) is owned by 42.48% institutional shareholders, 92.80% Imagenebio insiders, and 0.00% retail investors. Jean Francois Formela is the largest individual Imagenebio shareholder, owning 2.90M shares representing 25.95% of the company. Jean Francois Formela's Imagenebio shares are currently valued at $20.05M.

If you're new to stock investing, here's how to buy Imagenebio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.